Vox Sanguinis · 1988 · 44 citations · 24 references
MedicineInternal MedicinePathologyHepatologyHuman NutritionTransplant ImmunologyDonor EvaluationDonor SelectionHepatic Function TestingHepatic ImpairmentLiver DiseaseLiver Function TestsBody Weight AssessmentLiver Enzyme AbnormalitiesSerum Alanine AminotransferaseSteatosis Biomarkers
Five hundred consecutive healthy blood donors were tested for serum alanine aminotransferase (ALT) and 44 (8.8%) had increased levels. Donors with and without raised ALT were compared in several aspects but only weight (expressed as percentage of ideal body weight) and sex differed significantly (119.1 +/- 14.5 and 106.3 +/- 12.8%, respectively; p less than 0.001 and males 97.7 and 77.1%, respectively; p less than 0.01). The 44 donors with raised ALT were followed up and in 13 out of 15 donors with persistently raised ALT without obvious reason, a liver biopsy was performed. Ten donors had various degrees of liver steatosis, 2 had normal liver morphology and in 1 donor chronic hepatitis could not be ruled out. If ALT screening is introduced as a surrogate test for non-A, non-B hepatitis in Swedish blood donors, we suggest that a correction for overweight must be considered in order to minimize donor loss.
24